ITE, a novel endogenous nontoxic aryl hydrocarbon receptor ligand, efficiently suppresses EAU and T-Cell- mediated immunity

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 12, 2013, Pages 7463-7469

  Nugent, Lindsey F ^a   Shi, Guangpu ^a   Vistica, Barbara P ^a   Ogbeifun, Osato ^a   Hinshaw, Samuel J H ^a   Gery, Igal ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

Aryl hydrocarbon receptor ligand; Experimental autoimmune uveitis; T cell mediated immunity

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; IMMUNE RESPONSE; MOUSE; NONHUMAN; OPHTHALMOSCOPY; OPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UVEORETINITIS;

ARYL HYDROCARBON RECEPTOR LIGAND; EXPERIMENTAL AUTOIMMUNE UVEITIS; T-CELL MEDIATED IMMUNITY;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE PROTEINS; FEMALE; FLOW CYTOMETRY; IMMUNITY, CELLULAR; MICE; RETINOL-BINDING PROTEINS; T-LYMPHOCYTES, REGULATORY; UVEITIS;

EID: 84887851229     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11479     Document Type: Article

References (25)

1. Zhu J, Paul WE. Peripheral CD4{thorn} T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010; 238: 247-262.
2. Balasubramani A, Mukasa R, Hatton RD, Weaver CT. Regulation of the Ifng locus in the context of T-lineage specification and plasticity. Immunol Rev. 2010; 238: 216-232.
3. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr Opin Immunol. 2012; 24: 297-302.
4. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299: 1057-1061.
5. Shevach EM. Mechanisms of foxp3{thorn}T regulatory cell-mediated suppression. Immunity. 2009; 30: 636-645.
6. Korn T. How T cells take developmental decisions by using the aryl hydrocarbon receptor to sense the environment. Proc Natl Acad Sci U S A. 2010; 107: 20597-20598.
7. Veldhoen M, Duarte JH. The aryl hydrocarbon receptor: finetuning the immune-response. Curr Opin Immunol. 2010; 22: 747-752.
8. Gandhi R, Kumar D, Burns EJ, et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T celllike and Foxp3({thorn}) regulatory T cells. Nat Immunol. 2010; 11: 846-853.
9. Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008; 453: 106-109.
10. Constantinescu CS, Farooqi N, O'Brien K, Gran B. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol. 2011; 164: 1079-1106.
11. Pierson E, Simmons SB, Castelli L, Goverman JM. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol Rev. 2012; 248: 205-215.
12. Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008; 453: 65-71.
13. Zhang L, Ma J, Takeuchi M, et al. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest Ophthalmol Vis Sci. 2010; 51: 2109-2117.
14. Nussenblatt RB, Gery I. Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease. J Autoimmun. 1996; 9: 575-585.
15. Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest. 2010; 120: 3073-3083.
16. Song J, Clagett-Dame M, Peterson RE, et al. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc Natl Acad Sci U S A. 2002; 99: 14694-14699.
17. Quintana FJ, Murugaiyan G, Farez MF, et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 2010; 107: 20768-20773.
18. Pepperberg DR, Okajima TL, Ripps H, Chader GJ, Wiggert B. Functional properties of interphotoreceptor retinoid-binding protein. Photochem Photobiol. 1991; 54: 1057-1060.
19. Xu H, Koch P, Chen M, Lau A, Reid DM, Forrester JV. A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp Eye Res. 2008; 87: 319-326.
20. Hikita ST, Vistica BP, Jones HR, et al. Osteopontin is proinflammatory in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 2006; 47: 4435-4443.
21. Fujimoto C, Klinman DM, Shi G, et al. A suppressive oligodeoxynucleotide inhibits ocular inflammation. Clin Exp Immunol. 2009; 156: 528-534.
22. Shi G, Lovaas JD, Tan C, et al. Cell-cell interaction with APC, not IL-23, is required for naive CD4 cells to acquire pathogenicity during Th17 lineage commitment. J Immunol. 2012; 189: 1220-1227.
23. Codarri L, Gyulveszi G, Tosevski V, et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol. 2011; 12: 560-567.
24. El-Behi M, Ciric B, Dai H, et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat Immunol. 2011; 12: 568-575.
25. Kimura A, Naka T, Nohara K, Fujii-Kuriyama Y, Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci U S A. 2008; 105: 9721-9726.